tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market

Olema Pharmaceuticals (OLMA) Income Statement

Compare
703 Followers

Olema Pharmaceuticals Income Statement

Last quarter (Q3 2024), Olema Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Olema Pharmaceuticals's net income was $-34.55M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -377.00K$ -1.66M$ -1.66M$ -11.00K$ -9.03K
Operating Expenses
$ 104.96M$ 106.99M$ 71.49M$ 21.53M$ 4.32M
Depreciation and Amortization
$ 377.00K$ 1.66M$ 1.66M$ 11.00K$ 9.03K
EBITDA
$ -104.58M$ -103.13M$ -69.43M$ -21.52M$ -4.31M
Operating Income
$ -104.96M$ -106.99M$ -71.49M$ -21.53M$ -4.32M
Other Income/Expenses
$ 8.31M$ 2.20M$ 395.00K$ -593.00K$ 7.00K
Pretax Income
$ -96.66M$ -104.79M$ -71.10M$ -22.12M$ -4.32M
Net Income
$ -96.66M$ -102.59M$ -70.89M$ -22.76M$ -4.32M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.14$ -2.56$ -1.79$ -0.58$ -0.11
Diluted EPS
$ -2.14$ -2.56$ -1.79$ -0.58$ -0.11
Weighted Average Shares Outstanding
45.25M 40.00M 39.52M 39.31M 40.17M
Weighted Average Shares Outstanding (Diluted)
45.25M 40.00M 39.52M 39.31M 40.17M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis